CompoAtlas

Fenugrec

Food supplement declared in France, declaration No 2023-7-1436, decision dated 26 July 2023

Fenugrec is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
WELLPHARMA
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules
Directions for use
Prendre 2 gélules par jour, avec un grand verre d'eau
Not recommended for (according to the manufacturer)
Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Digestion, Grossesse et allaitement

Declaration 311643, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Trigonella foenum-graecum L.GraineExtrait sec aqueux450 mg
Trigonella foenum-graecum L.GrainePoudre (de plantes séchées ou broyées)200 mg

Additives

E464

Other ingredients

maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2023. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Réservé à l'adulte. Déconseillé chez la femme enceinte.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line